XML 43 R32.htm IDEA: XBRL DOCUMENT v3.21.1
Share-Based Compensation (Tables)
3 Months Ended
Mar. 31, 2021
Share-based Payment Arrangement [Abstract]  
Total Share-Based Compensation Expense
Total share-based compensation expense was as follows:
Three Months Ended
March 31,
20212020
(In thousands)
Stock option expense$3,923 $3,373 
Restricted stock expense6,227 3,542 
Performance restricted stock unit expense1,290 933 
Total pre-tax expense$11,440 $7,848 
Weighted Average Assumptions Used for Estimating Fair Values of Stock Options Granted The following weighted average assumptions were used in the Black-Scholes-Merton model to estimate the fair values of stock options granted during the periods indicated:
Three Months Ended
March 31, 2021
Year Ended December 31,
2020
Expected volatility24.2 %22.2 %
Expected term (years)5.05.0
Risk-free interest rate0.85 %0.52 %
Expected dividend yield0.66 %1.14 %
Black-Scholes-Merton fair value per stock option granted$25.63 $11.01 
Summary of Stock Option Activity and Related Information
The following is a summary of the Company’s stock option activity and related information:
SharesWeighted
Average
Exercise
Price
Weighted
Average
Remaining
Contractual
Life 
Aggregate
Intrinsic
Value
(In thousands)(Years)(In millions)
Outstanding at December 31, 20203,950 $65.16 
Granted552 121.91 
Exercised(171)55.22 
Forfeited(20)70.87 
Outstanding at March 31, 20214,311 $72.80 6.4$236.8 
Exercisable at March 31, 20212,180 $61.60 4.7$144.1 
Summary of Nonvested Restricted Stock Activity and Related Information
The following is a summary of the Company’s non-vested restricted stock activity and related information:
SharesWeighted
Average
 Grant Date
Fair Value
(In thousands)
Non-vested restricted stock outstanding at December 31, 2020701 $76.86 
Granted146 121.91 
Vested(209)61.57 
Forfeited(5)84.46 
Non-vested restricted stock outstanding at March 31, 2021633 $92.25 
The following is a summary of the Company’s non-vested performance restricted stock activity and related information:
SharesWeighted
Average
 Grant Date
Fair Value
(In thousands)
Non-vested performance restricted stock outstanding at December 31, 2020264 $72.90 
Granted81 121.91 
Performance assumption change 139 78.20 
Vested(88)78.20 
Forfeited(1)67.43 
Non-vested performance restricted stock outstanding at March 31, 2021295 $85.43